Scholars@Duke

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19.

Publication ,  Journal Article
Mylonakis, E; Barkauskas, C; Poulakou, G; Young, BE; ACTIV-3/TICO Study Group*,
Published in: Ann Intern Med
February 2023
Published version (DOI) Link to item

Duke Scholars

Christina Eleanor Barkauskas
Author Christina Eleanor Barkauskas Medicine, Pulmonary, Allergy, and Critical Care Medicine

Published In

Ann Intern Med

DOI

10.7326/L22-0456

EISSN

1539-3704

Publication Date

February 2023

Volume

176

Issue

2

Start / End Page

eL220456

Location

United States

Related Subject Headings

  • SARS-CoV-2
  • Recombinant Fusion Proteins
  • Humans
  • Hospitalization
  • General & Internal Medicine
  • COVID-19
  • Adult
  • 3202 Clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mylonakis, E., Barkauskas, C., Poulakou, G., Young, B. E., & ACTIV-3/TICO Study Group*, . (2023). Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19. Ann Intern Med, 176(2), eL220456. https://doi.org/10.7326/L22-0456
Mylonakis, Eleftherios, Christina Barkauskas, Garyfallia Poulakou, Barnaby E. Young, and Barnaby E. ACTIV-3/TICO Study Group*. “Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19.” Ann Intern Med 176, no. 2 (February 2023): eL220456. https://doi.org/10.7326/L22-0456.
Mylonakis E, Barkauskas C, Poulakou G, Young BE, ACTIV-3/TICO Study Group*. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19. Ann Intern Med. 2023 Feb;176(2):eL220456.
Mylonakis, Eleftherios, et al. “Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19.” Ann Intern Med, vol. 176, no. 2, Feb. 2023, p. eL220456. Pubmed, doi:10.7326/L22-0456.
Mylonakis E, Barkauskas C, Poulakou G, Young BE, ACTIV-3/TICO Study Group*. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19. Ann Intern Med. 2023 Feb;176(2):eL220456.

Published In

Ann Intern Med

DOI

10.7326/L22-0456

EISSN

1539-3704

Publication Date

February 2023

Volume

176

Issue

2

Start / End Page

eL220456

Location

United States

Related Subject Headings

  • SARS-CoV-2
  • Recombinant Fusion Proteins
  • Humans
  • Hospitalization
  • General & Internal Medicine
  • COVID-19
  • Adult
  • 3202 Clinical sciences
  • 11 Medical and Health Sciences